The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.
A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney cancer, according to results of a phase 1 trial.All nine study participants — who had undergone surgery for stage III or stage IV clear cell renal cell carcinoma — remained cancer free approximately 3 years after treatment.
Trump administration officials have canceled a federal vaccine advisory committee meeting expected to be held next month that was intended to help select the makeup of next winter’s influenza ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results